Cross-Sectional Analysis of Biologic Use in the Treatment of Veterans With Hidradenitis Suppurativa.

Remicade (infliximab) - J&J

Bimzelx (bimekizumab-bkzx) - UCB

Humira (adalimumab) - AbbVie

Cosentyx (secukinumab) - Novartis

http://www.ncbi.nlm.nih.gov/pubmed/42713230

Amit Garg; Amy A Gravely; Claire Herzog; Fatai Y Agiri; Julie A Lynch; Katelyn Rypka; Kathryn M Pridgen; Lauren Orenstein; Lindsey Greenlund; Noah Goldfarb; Zachary Wendland

Sep 10, 2026